Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Testosterone Administration Suppresses Adiponectin Levels in Men

Open access
Page, Stephanie T., Herbst, Karen L., Amory, John K., Coviello, Andrea D., Anawalt, Bradley D., Matsumoto, Alvin M., Bremner, William J.·2005·Journal of Andrology

Abstract

ABSTRACT: Testosterone (T) administration to men increases lean body mass and decreases fat mass. Adiponectin is produced by adipocytes and is thought to influence insulin sensitivity. In this study, we sought to determine whether experimental alterations in serum T change adiponectin levels in normal men. We measured adiponectin levels in 28 healthy men ages 18–35 years before and during treatment with a potent gonadotropin‐releasing‐hormone (GnRH) antagonist, acyline. Decreased T levels led to increased serum adiponectin within 7 days; maximal adiponectin levels were reached on day 21 (baseline 8.6 ± 0.9 compared with 12.2 ± 1.0 μg/mL on day 21, P < .05) and persisted through day 30, despite no significant changes in body mass index (BMI) and an increase in leptin. The addition of T to acyline, maintaining serum T levels within the normal range, prevented the increase in adiponectin following acyline alone. In a second study, 25 men aged 55–85 years were treated with 3 weeks of high‐dose T (testosterone enanthate [TE], 600 mg/wk intramuscularly). With high serum T levels, adiponectin levels decreased significantly by day 21 of treatment (baseline 14.3 ± 1.9 compared with 10.8 ± 1.5 μg/mL, P < .05 vs baseline and placebo), BMI slightly increased, and leptin levels were decreased. We conclude that adiponectin levels increase within days of experimental T deficiency in normal men, and the increase in adiponectin is prevented by T replacement. Furthermore, supraphysiologic T administration results in decreased adiponectin levels. Our data support the hypothesis that T, its metabolites, or both directly suppress adipocyte production of adiponectin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1939-4640.2005.tb02876.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 40

  1. 10.1046/j.1532-5415.2002.50462.x · DOI
  2. 10.1046/j.1365-2265.2002.01551.x · DOI · Paper page
  3. 10.1016/S1043-2760(01)00524-0 · DOI · Paper page
  4. 10.1056/NEJM199607043350101 · DOI · Paper page
  5. 10.1210/jc.82.2.407 · DOI · Paper page
  6. 10.1007/s00125-003-1074-z · DOI · Paper page
  7. 10.1152/ajpcell.1998.274.6.C1645 · DOI · Paper page
  8. 10.1042/CS20020209 · doi:10.1042/cs20020209 · Paper page
  9. 10.1210/jc.2003-030219 · DOI
  10. 10.1001/jama.289.14.1799 · DOI · Paper page
  11. 10.1210/jcem-68-5-971 · DOI
  12. 10.1034/j.1601-5215.2002.51018.x · DOI · Paper page
  13. 10.1074/jbc.274.23.16147 · DOI
  14. 10.1152/ajpendo.00524.2002 · DOI
  15. Herbst KL, 2002, Acyline: the first study in humans of a potent, new gonadotropin‐releasing hormone antagonist, J Clin Endocrinol Metab, 87, 3215, 10.1210/jcem.87.7.8675 · DOI
  16. 10.1210/jc.2002-020918 · DOI
  17. Herbst KL, A single dose of the potent gonadotropin releasing hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men, JCEM
  18. 10.1161/01.ATV.20.6.1595 · DOI · Paper page
  19. 10.2337/diabetes.50.5.1126 · DOI · Paper page
  20. 10.2337/diabetes.52.7.1655 · DOI · Paper page
  21. 10.1074/jbc.C200251200 · DOI · Paper page
  22. 10.1111/j.1365-2265.2004.02007.x · DOI · Paper page
  23. 10.1530/eje.0.1480055 · DOI
  24. Lovejoy JC, 1995, Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men, Int J Obes Relat Metab Disord, 19, 614
  25. 10.2337/diabetes.50.9.2094 · DOI · Paper page
  26. Marin P., 1992, The effects of testosterone treatment on body composition and metabolism in middle‐aged obese men, Int J Obes Relat Metab Disord, 16, 991
  27. Marin P., 1992, Androgen treatment of middle‐aged, obese men: effects on metabolism, muscle and adipose tissues, Eur J Med, 1, 329
  28. 10.1042/0264-6021:3610629 · doi:10.1042/0264-6021:3610629
  29. 10.1373/49.4.650 · DOI
  30. 10.1210/en.2003-0580 · DOI · Paper page
  31. 10.1152/ajpendo.00363.2002 · DOI
  32. 10.1016/S0960-9822(98)70133-2 · DOI · Paper page
  33. 10.1210/jcem.87.1.8172 · doi:10.1210/jcem.87.1.8172 · Paper page
  34. 10.1210/en.2003-0741 · DOI · Paper page
  35. 10.1210/jcem.86.9.7851 · DOI · Paper page
  36. 10.1210/jc.2003-031492 · DOI · Paper page
  37. 10.1038/90984 · DOI · Paper page
  38. 10.1210/jcem.86.8.7741 · doi:10.1210/jcem.86.8.7741 · Paper page
  39. 10.1073/pnas.93.11.5517 · DOI · Paper page
  40. 10.2337/diabetes.51.10.2968 · DOI · Paper page

Cited by

See all 162

Metadata

Authors
Page, S. T., Herbst, K. L., Amory, J. K., Coviello, A. D., Anawalt, B. D., Matsumoto, A. M., & Bremner, W. J.
Venue
Journal of Andrology
Publisher
Wiley
Published
2005-01-02
Volume
26
Issue
1
Pages
85-92
ISSN
  • 0196-3635 (ISSN-L)
  • 1939-4640
OpenAlex
W1569805885
Cited by
162
References
6
FWCI
6.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Testosterone Administration Suppresses Adiponectin Levels in Men. https://app.cochat.ai/papers/10.1002/j.1939-4640.2005.tb02876.x
The paper
Page, S. T., Herbst, K. L., Amory, J. K., Coviello, A. D., Anawalt, B. D., Matsumoto, A. M., & Bremner, W. J. (2005). Testosterone Administration Suppresses Adiponectin Levels in Men. Journal of Andrology. https://doi.org/10.1002/j.1939-4640.2005.tb02876.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.